TY - JOUR
T1 - Health-care transitions for young people living beyond childhood and adolescent cancer
T2 - recommendations from the EU–CAYAS–NET consortium
AU - Wams, Jikke
AU - van Dalen, Elvira C.
AU - den Hartogh, Jaap G.
AU - Otth, Maria
AU - Costa, Tiago
AU - Gorter, Jan Willem
AU - van der Aa-van Delden, Alied M.
AU - Panasiuk, Anna
AU - Wörmann, Bernhard
AU - Berger, Claire
AU - Bardi, Edit
AU - Larsen, Elna Hamilton
AU - Potter, Emma
AU - Soria, Esther Lasheras
AU - Levitt, Gill
AU - Michel, Gisela
AU - van der Pal, Helena J.H.
AU - Roganovic, Jelena
AU - de Bont, Judith
AU - Wauters, Lieselotte
AU - Pelanconi, Lisa
AU - Zaletel, Lorna Zadravec
AU - Balcerek, Magdalena
AU - Muraca, Monica
AU - Brown, Morven C.
AU - Asogwa, Ogechukwu A.
AU - de Sousa, Oriana
AU - Koopman, Rianne
AU - Mehta, Susan
AU - Papadakis, Vassilios
AU - Kremer, Leontien C.M.
AU - Skinner, Roderick
AU - Scheinemann, Katrin
AU - Mulder, Renée L.
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/10
Y1 - 2025/10
N2 - Childhood and adolescent cancer survivors (age at diagnosis: 0–21 years) face increased risk for long-term health complications and less favourable outcomes in terms of functioning and social participation. Moreover, they often experience inadequate health-care transitions to appropriate services after leaving paediatric or adolescent services, while the prevalence and severity of late effects increase as they become adults. To address transition challenges, we developed evidence-based recommendations as part of the European Network of Youth Cancer Survivors project with the goal to improve health-care transitions to both long-term survivorship and adult care, ensuring continuity and addressing survivors’ unique needs. Using evidence-based methods, an international and multidisciplinary guideline panel developed a clinical practice guideline for health-care transitions. Patient representatives were included at all steps of the development process. The guideline panel systematically reviewed data from PubMed from Jan 1, 1990, to April 8, 2025, and graded the evidence with the GRADE methodology. In addition, existing guidelines and perspectives from patients, parents, and health-care providers were considered when formulating recommendations. Of 2538 citations identified, 86 articles met the inclusion criteria, focusing on health-care transitions for cancer survivors up to age 21 years at diagnosis or for patients with chronic conditions (eg, diabetes and asthma) to extrapolate insights from these populations. The quality of evidence varied from very low to moderate. Unique needs and preferences were captured, ensuring a comprehensive and patient-centred approach to the recommendations. In total, 44 strong recommendations were formulated for health-care transitions of childhood and adolescent cancer survivors. We integrated existing evidence and multistakeholder expertise and developed actionable recommendations that support smooth transitions for childhood and adolescent cancer survivors and improve their lives as adults. Implementing this guideline will enhance the quality of care and improve quality of life by addressing the specific health-care transition needs of this vulnerable population.
AB - Childhood and adolescent cancer survivors (age at diagnosis: 0–21 years) face increased risk for long-term health complications and less favourable outcomes in terms of functioning and social participation. Moreover, they often experience inadequate health-care transitions to appropriate services after leaving paediatric or adolescent services, while the prevalence and severity of late effects increase as they become adults. To address transition challenges, we developed evidence-based recommendations as part of the European Network of Youth Cancer Survivors project with the goal to improve health-care transitions to both long-term survivorship and adult care, ensuring continuity and addressing survivors’ unique needs. Using evidence-based methods, an international and multidisciplinary guideline panel developed a clinical practice guideline for health-care transitions. Patient representatives were included at all steps of the development process. The guideline panel systematically reviewed data from PubMed from Jan 1, 1990, to April 8, 2025, and graded the evidence with the GRADE methodology. In addition, existing guidelines and perspectives from patients, parents, and health-care providers were considered when formulating recommendations. Of 2538 citations identified, 86 articles met the inclusion criteria, focusing on health-care transitions for cancer survivors up to age 21 years at diagnosis or for patients with chronic conditions (eg, diabetes and asthma) to extrapolate insights from these populations. The quality of evidence varied from very low to moderate. Unique needs and preferences were captured, ensuring a comprehensive and patient-centred approach to the recommendations. In total, 44 strong recommendations were formulated for health-care transitions of childhood and adolescent cancer survivors. We integrated existing evidence and multistakeholder expertise and developed actionable recommendations that support smooth transitions for childhood and adolescent cancer survivors and improve their lives as adults. Implementing this guideline will enhance the quality of care and improve quality of life by addressing the specific health-care transition needs of this vulnerable population.
KW - Adolescent
KW - Cancer Survivors
KW - Child
KW - Child, Preschool
KW - Humans
KW - Infant
KW - Neoplasms/therapy
KW - Systematic Reviews as Topic
KW - Transition to Adult Care/standards
KW - Young Adult
UR - https://www.scopus.com/pages/publications/105017423231
U2 - 10.1016/S1470-2045(25)00410-3
DO - 10.1016/S1470-2045(25)00410-3
M3 - Review article
C2 - 41038201
AN - SCOPUS:105017423231
SN - 1470-2045
VL - 26
SP - e525-e535
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 10
ER -